Skip to content

Clinical trials

Phase 2 Leukemia, Lymphocytic, Chronic, B-Cell trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Lymphocytic, Chronic, B-Cell Phase: Phase 2 Country / region: United Kingdom Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20063
20074
20081
20092
20101
20112
20121
20131
20141
20163
20171
20222
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated7
Active, not recruiting3
Recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Biogen2
Gilead Sciences2
University College, London2
Acerta Pharma BV1
Cancer Research UK1
Celgene1
Cellectar Biosciences, Inc.1
Cephalon1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Lymphocytic, Chronic, B-Cell27
Leukemia5
Lymphoma4
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell, Marginal Zone3
Lymphoma, Follicular3
Recurrence3
Waldenstrom Macroglobulinemia3
Bronchiolitis Obliterans Syndrome2
Hodgkin Disease2

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.